FORM OF 6% CONVERTIBLE NOTE DUE 2005Alliance Pharmaceutical Corp • February 14th, 2001 • In vitro & in vivo diagnostic substances
Company FiledFebruary 14th, 2001 Industry
AMENDMENT NO. 2License Agreement • February 14th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 14th, 2001 Company Industry
EXHIBIT 10(b) CONSULTING AGREEMENT THIS CONSULTING AGREEMENT made as of this 1st day of July, 2000 (the "Agreement") by and between Alliance Pharmaceutical GmbH, a German corporation (the "Company") and Jean Riess, whose address is Les Giaines, 06950...Consulting Agreement • February 14th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 14th, 2001 Company Industry
Form of COLLATERAL PLEDGE AND SECURITY AGREEMENTPledge and Security Agreement • February 14th, 2001 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 14th, 2001 Company Industry Jurisdiction